寄托家园留学论坛 › 论坛 › 寄托学术类备考版 › GRE作文互动版 › Argument5 高频第2篇希望大家猛砸哦!给连接,互拍!

返回列表

查看: 624|回复: 5

[a习作temp] Argument5 高频第2篇希望大家猛砸哦!给连接,互拍! [复制链接]

阿择菜
UID: 2110339

中级会员

Rank: 4

声望: 0
寄托币: 974
注册时间: 2005-6-21
精华: 1
帖子: 3

电梯直达

楼主

发表于 2005-7-24 10:32:58 |只看该作者 |倒序浏览

Argument5 第3篇让砖头来得更猛烈些吧！
------摘要------
作者：寄托家园作文版普通用户共用时间：30分2秒 327 words
从2005年6月24日10时11分到2005年6月24日10时30分
------题目------
The following appeared in the business section of a newspaper.
'Given that the number of people in our country with some form of arthritis is expected to rise from 40 million to 60 million over the next twenty years, pharmaceutical companies that produce drugs for the treatment of arthritis should be very profitable. Many analysts believe that in ten years Becton Pharmaceuticals, which makes Xenon, the best-selling drug treatment for arthritis, will be the most profitable pharmaceutical company. But the patent on Xenon expires in three years, and other companies will then be able to produce a cheaper version of the drug. Thus, it is more likely that in ten years the most profitable pharmaceutical company will be Perkins Pharmaceuticals, maker of a new drug called Xylan, which clinical studies show is preferred over Xenon by seven out of ten patients suffering from the most extreme cases of arthritis.'
------正文------
The argument want to support the Becton Pharmaceutical Company(BP) will make the profitable than the Perkins Pharmaceutical Company(PP) by producing a new drug called the Xenon in the next ten years. The arguer supports some statistics and a study which proved his conclusion is warranted. Nevertheless, a careful examination of the argument is how groudness in it.
In the first place, the arguer provides the numbers of the arthritis in the next 20 years which is qustionable. No one gives the numbers of the enrollment population. So from 40 million to 60 million, we can't have enough evidence to proved the rate of the patient increases rapidly.
In the second place, even though the numbers of the arthritis patient increases in the future, the patient will not be certain to use the drugs to treat. As the technology developing fast, other treatment may cure the arthritis much better, and the pains is less and less. The patient who don't have the medicine will recuperate like others. So if the treatments are used widely, who will buy the drug of arthritis?
Finally, there is no complete evidence to proved that the Xenon is used spread than the Xylan by studying 10 patients. The statistics of the population is too small, we can't draw a conclusion to infer the population through the small sample. Also, are the patients in the sample random and independent samples? Even the patient now choose the Xenon, there will not enough evidences to choose the Xylan in the future. Maybe the Xylan is much more cheap in all probability than the Xylan in the future.
In sum, whether the BP company will make profitable by producing the Xenon will be provided more evidences. The argument should make clear that the date rates in the population and survey many more patients in the hospital. In addition, the argument should clarify the revenue and the cost of the company, so we can infer it will or not make a profit.

共同进步!QQ:23511460GRE研讨论群:9359511

回应
0

使用道具举报

raincol
UID: 2113651

中级会员

Rank: 4

声望: 0
寄托币: 437
注册时间: 2005-7-5
精华: 0
帖子: 3

沙发

发表于 2005-7-24 11:03:41 |只看该作者

字数最好再多些。这样保险点。

【2025FALL】全站祈福已开放~~来领祈福章，求offer得offer

使用道具举报

阿择菜
UID: 2110339

中级会员

Rank: 4

声望: 0
寄托币: 974
注册时间: 2005-6-21
精华: 1
帖子: 3

板凳

发表于 2005-7-24 15:22:59 |只看该作者

恩 i think so,but i accomplished in the limited time, i'll try my best
!!!~~~

共同进步!QQ:23511460GRE研讨论群:9359511

使用道具举报

yuchen
UID: 2111079

中级会员

Rank: 4

声望: 0
寄托币: 759
注册时间: 2005-6-24
精华: 0
帖子: 1

地板

发表于 2005-7-24 16:03:01 |只看该作者

argument 5是高频吗？

gter上的机井显示argument 5一次也没考过呀！
第四题倒是最高频！

It does not do to dwell on dreams and forget to live.

使用道具举报

laihs288
UID: 166652

寄托新兵

Rank: 2

声望: 0
寄托币: 98
注册时间: 2004-6-10
精华: 0
帖子: 18

5楼

发表于 2005-7-25 23:23:40 |只看该作者

------题目------
The following appeared in the business section of a newspaper.
'Given that the number of people in our country with some form of arthritis is expected to rise from 40 million to 60 million over the next twenty years, pharmaceutical companies that produce drugs for the treatment of arthritis should be very profitable. Many analysts believe that in ten years Becton Pharmaceuticals, which makes Xenon, the best-selling drug treatment for arthritis, will be the most profitable pharmaceutical company. But the patent on Xenon expires in three years, and other companies will then be able to produce a cheaper version of the drug. Thus, it is more likely that in ten years the most profitable pharmaceutical company will be Perkins Pharmaceuticals, maker of a new drug called Xylan, which clinical studies show is preferred over Xenon by seven out of ten patients suffering from the most extreme cases of arthritis.'
------正文------
The argument wants to support the Becton Pharmaceutical Company(BP) will make the profitable than the Perkins Pharmaceutical Company(PP) by producing a new drug called the Xenon in the next ten years. （结论有问题，不是比较，而是说Perkins Pharmaceuticals will be the most profitable pharmaceutical company）The arguer supports(cites) some statistics and a study which proved his conclusion is warranted. Nevertheless, a careful examination of the argument is how groudness in it.
In the first place, the arguer provides the numbers of the arthritis in the next 20 years which is qustionable. No one gives the numbers of the enrollment population. So from 40 million to 60 million, we can't have enough evidence to proved the rate of the patient increases rapidly.（这个我觉得是小错误）

In the second place, even though the numbers of the arthritis patient increases in the future, the patient will not be certain to use the drugs to treat. As the technology developing fast, other treatment may cure the arthritis much better, and the pains is less and less. The patient who don't have the medicine will recuperate like others. So if the treatments are used widely, who will buy the drug of arthritis?(这段应该重点展开)

Finally, there is no complete evidence to proved that the Xenon is used spread than the Xylan by studying 10 patients. （是十分之七吧？而不是只有十个受试者）The statistics of the population is too small, we can't draw a conclusion to infer the population through the small sample. Also, are the patients in the sample random and independent samples? Even the patient now choose the Xenon, there will not enough evidences to choose the Xylan in the future. Maybe the Xylan is much more cheap in all probability than the Xylan in the future.（还有就是the study subjects are not representative enough.注意他们仅仅是suffering from the most extreme cases of arthritis.'）
还有一个错误：commits a fallacy of false dilemma:可能除了这两个公司，还有其它公司呢？可能是其它某个公司的利润最高。
In sum, whether the BP company will make profitable by producing the Xenon will be provided more evidences. The argument should make clear that the date rates in the population and survey many more patients in the hospital. In addition, the argument should clarify the revenue and the cost of the company, so we can infer it will or not make a profit.
帮我拍拍吧https://bbs.gter.net/viewthre ... type%26typeid%3D102

我们的愿望！

使用道具举报

阿择菜
UID: 2110339

中级会员

Rank: 4

声望: 0
寄托币: 974
注册时间: 2005-6-21
精华: 1
帖子: 3

6楼

发表于 2005-7-26 10:00:30 |只看该作者

Argument5 第3篇让砖头来得更猛烈些吧！
------摘要------
作者：寄托家园作文版普通用户共用时间：30分2秒 327 words
从2005年6月24日10时11分到2005年6月24日10时30分
------题目------
The following appeared in the business section of a newspaper.
'Given that the number of people in our country with some form of arthritis is expected to rise from 40 million to 60 million over the next twenty years, pharmaceutical companies that produce drugs for the treatment of arthritis should be very profitable. Many analysts believe that in ten years Becton Pharmaceuticals, which makes Xenon, the best-selling drug treatment for arthritis, will be the most profitable pharmaceutical company. But the patent on Xenon expires in three years, and other companies will then be able to produce a cheaper version of the drug. Thus, it is more likely that in ten years the most profitable pharmaceutical company will be Perkins Pharmaceuticals, maker of a new drug called Xylan, which clinical studies show is preferred over Xenon by seven out of ten patients suffering from the most extreme cases of arthritis.'
------正文------
The argument want to support the Becton Pharmaceutical Company(BP) will make the most profitable than any company including the Perkins Pharmaceutical Company(PP) by producing a new drug called the Xenon in the next ten years. The arguer supports some statistics and a study which proved his conclusion is warranted. Nevertheless, a careful examination of the argument is how groudness in it.

In the first place, the arguer provides the numbers of the arthritis in the next 20 years which is qustionable. No one gives the numbers of the enrollment population. So from 40 million to 60 million, we can't have enough evidence to prove the rate of the patient increases rapidly.Aditionally,the arguer concludes that the PP will the most profitbal company only camparing the BP company,perhaps there are more other drug company indeed.

In the second place, even though the numbers of the arthritis patient increases in the future, the patient will not be certain to use the drugs to treat. As the technology developing fast, other treatment may cure the arthritis much better, and the pain is less and less. The patient who don't have the medicine will recuperate like others. So if the treatments are used widely, who will buy the drug of arthritis?Moreover,the profit is relation between revenue and cost.Even though the revenue increases,the cost is not certain to spend lower.The cost cantains t the expense ofhe original medical material, the advertisement,the transportion and so on.Therefore, there is not insufficient evidence to conclued that the drug could bring us more profit.

Finally, there is no complete evidence to proved that the Xenon is used spread than the Xylan by studying the population of patients. The statistics of the sample is not certain, we can't draw a conclusion to infer the population through the small sample. Also, are the patients in the sample random and independent samples? Even the patient now choose the Xenon, there will not enough evidences to choose the Xylan in the future. Maybe the Xylan is much more cheap in all probability than the Xylan in the future.
In sum, whether the BP company will make profitable by producing the Xenon will be provided more evidences. The argument should make clear that the date rates in the population and survey many more patients in the hospital. In addition, the argument should clarify the revenue and the cost of the company, so we can infer it will or not make a profit.

楼主,你的建议很好,我已经又完善完善的我的AGU了,thank u!~~~~

共同进步!QQ:23511460GRE研讨论群:9359511

使用道具举报